Advertisement
Advertisement
OGI
Organigram Global Inc. Common Shares
1.05
USDSponsored
+0.06
+6.06%
Aug 10, 15:59 UTC -4
Closed
After-Market
1.07
+0.02
+1.90%
OGI Earnings Reports
Positive Surprise Ratio
OGI beat 19 of 39 last estimates.
49%
Next Report
Tomorrow BMO
Date of Next Report
Aug 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$99.74M
/$0.00
Implied change from Q2 26 (Revenue/ EPS)
+66.81%
/--
Implied change from Q3 25 (Revenue/ EPS)
+40.89%
/-100.00%
Organigram Global Inc. Common Shares earnings per share and revenue
On May 12, 2026, OGI reported earnings of 0.00 USD per share (EPS) for Q2 26, beating the estimate of -0.01 USD, resulting in a 30.69% surprise. Revenue reached 59.79 million, compared to an expected 71.32 million, with a -16.17% difference. The market reacted with a -15.27% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 99.74 million USD, implying an increase of 0.00% EPS, and increase of 66.81% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
CeriBell, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.48
Actual
-$0.51
Surprise
-6.10%
Varex Imaging Corporation Common Stock
Report Date
Aug 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.31
Surprise
+44.93%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Accendra Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.19
Surprise
-113.00%
Quanterix Corporation Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.45
Surprise
+4.09%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
What were Organigram Global Inc. Common Shares's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Organigram Global Inc. Common Shares reported EPS of $0.00, beating estimates by 30.69%, and revenue of $59.79M, -16.17% below expectations.
How did the market react to Organigram Global Inc. Common Shares's Q2 2026 earnings?
The stock price moved down -15.27%, changed from $1.31 before the earnings release to $1.11 the day after.
When is Organigram Global Inc. Common Shares expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Organigram Global Inc. Common Shares's next earnings report?
Based on 3
analysts, Organigram Global Inc. Common Shares is expected to report EPS of -- and revenue of $99.74M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement